文章引用说明 更多>> (返回到该文章)

张国天, 陈永生, 梁海军. 奥美沙坦治疗原发性高血压临床疗效分析[J]. 中国医院药学杂志, 2013, 33(11): 881-884.

被以下文章引用:

  • 标题: 奥美沙坦酯杂质A和C的合成Syntheses of Impurity A and C of Olmesartan Medoxomil

    作者: 李维思, 陈国萍, 范鑫, 唐景玉

    关键字: 奥美沙坦酯, 杂质A和C, 合成Olmesartan Medoxomil, Impurity A and C, Syntheses

    期刊名称: 《Pharmacy Information》, Vol.5 No.2, 2016-04-29

    摘要: 目的:优化和改进奥美沙坦酯杂质A和C的合成反应条件,提供了一条简单实用的合成奥美沙坦酯杂质A和C杂质对照品的路线。方法:杂质A由原料1通过一步酸解脱除三苯甲基保护基,然后用丙酮重结晶得到,而杂质C则通过原料2经叔醇官能团脱水成双键和酸解脱除三苯甲基保护基两步反应,最后通过柱层析得到。结果:优化了反应条件,重现性好,纯度大于95%符合杂质对照品要求。结论:本方法反应方法操作简单实用,重现性好。 Objective: A synthetic method towards impurity A and C of olmesartan medoxomil has been pro-vided through optimizing literature reaction conditions. Methods: Impurity A was directly obtained by acidic-removal of Trt protecting group of starting material 1 with subsequent recrystallization from acetone, whereas impurity C was afforded through dehydration of tertiary alcohol group of starting material 2 followed by acidic-removal of Trt protecting group. Results: Through optimization of literature reaction condition, impurity A and C with chemical purity greater than 95% can be readily obtained. Conclusion: The current method towards impurity A and C is simple and practical with good reproductivity.

在线客服:
对外合作:
联系方式:400-6379-560
投诉建议:feedback@hanspub.org
客服号

人工客服,优惠资讯,稿件咨询
公众号

科技前沿与学术知识分享